— Know what they know.
Not Investment Advice

GENN OTC

Genesis Healthcare, Inc.
1W: +0.0% 1M: +0.0% 3M: -50.0% 1Y: -90.9% 3Y: -99.9% 5Y: -100.0%
$0.00
Last traded 2025-08-18 — delisted
OTC · Healthcare · Medical - Care Facilities · $12146 mcap · 112M float · 0.0049% daily turnover · Short 4% of daily vol

Analyst Insights

Wall Street analyst consensus based on price targets and buy/sell/hold recommendations from institutional research coverage over the trailing 12 months.

Analyst Price Targets
Analyst Recommendations
Strong Buy: 0Buy: 5Hold: 5Sell: 3Strong Sell: 0
Rating Summary
ConsensusBuy
Avg Target$—
Analysts0

InsiderStreet Scorecard

Proprietary multi-factor scorecard rating companies across seven fundamental dimensions — profitability, balance sheet strength, earnings quality, growth, value, momentum, and safety — each scored 0–100.

★ ★ ★ ★ ★ 9 Grade D
Profitability
9
Balance Sheet
19
Earnings Quality
47
Growth
53
Value
56
Momentum
19
Safety
15
Cash Flow
8
The InsiderStreet Scorecard rates companies across eight dimensions: Profitability (margins, ROA, ROE), Balance Sheet (leverage, liquidity, coverage), Earnings Quality (accruals, cash conversion), Growth (revenue and earnings trajectory), Value (P/E, P/B, earnings yield, Graham criteria), Momentum (revenue and earnings acceleration), Safety (Altman Z-Score risk adjustment), and Cash Flow (operating cash flow quality, FCF conversion, cash coverage). The overall score blends 35% quality, 35% value, and 30% momentum, with a penalty for distress-zone Altman scores. GENN scores highest in Value (56/100) and lowest in Cash Flow (8/100). A grade of D flags significant fundamental concerns across multiple dimensions.

Risk & Quality Signals

Academic financial models used by institutional investors to assess bankruptcy risk, earnings manipulation, financial strength, and credit quality.

Altman Z-Score
0.14
Distress Zone
Piotroski F-Score
3/9
✓ ✗ ✓ ✗ ✓ ✗ ✗ ✗ ✗
Beneish M-Score
5.37
Possible Manipulator
Ohlson O-Score
-3.14
Bankruptcy prob: 4.1%
Low Risk
Credit Rating
CCC
Score: 17.3/100
Trend: Stable
Earnings Quality
25/100
OCF/NI: -0.47x
Accruals: 3.6%
The Altman Z-Score (1968) combines five ratios — working capital, retained earnings, EBIT, market value of equity, and sales, all relative to total assets or liabilities — into a single bankruptcy predictor. GENN scores 0.14, placing it in the Distress Zone (safe > 2.99, distress < 1.81). Historically, companies in this range face elevated bankruptcy risk. The Piotroski F-Score (2000) is a 9-point binary checklist — four profitability tests (positive ROA, positive cash flow, improving ROA, cash flow exceeding net income), three leverage tests (declining debt ratio, improving current ratio, no share dilution), and two efficiency tests (improving gross margin, improving asset turnover). Each pass scores 1 point. GENN scores 3/9, suggesting weak financial fundamentals — the company fails the majority of these accounting tests. The Beneish M-Score (1999) is an 8-variable model that detects earnings manipulation by comparing year-over-year changes in receivables, gross margins, asset quality, sales growth, depreciation, SG&A, leverage, and accruals. Scores above −1.78 statistically resemble past manipulators. GENN's score of 5.37 exceeds the −1.78 red flag threshold — this does not confirm manipulation but indicates the earnings profile resembles past manipulators statistically. The Ohlson O-Score (1980) is a 9-variable logistic regression that estimates bankruptcy probability using firm size, leverage, working capital, current ratio, profitability (ROA), cash flow coverage, negative equity flag, consecutive losses flag, and earnings trajectory. The raw score is converted to a probability via logistic transformation. GENN's implied 4.1% bankruptcy probability is well within safe territory. Our Credit Rating model scores companies on five weighted components — solvency (30%), earning power (25%), leverage (20%), liquidity (15%), and cash flow quality (10%) — then blends the absolute score with sector and industry peer rankings. For companies with large buyback programs, equity is adjusted by adding back cumulative 5-year repurchases (capped at 80% of FCF generated) to avoid penalizing shareholder-friendly capital allocation. GENN receives an estimated rating of CCC (score: 17.3/100), with a stable trend. The Earnings Quality score measures how well reported earnings are backed by real cash. It evaluates the operating cash flow to net income ratio (OCF/NI ≥ 1.0 means every dollar of earnings is cash-backed) and the accruals ratio (the gap between earnings and cash flow relative to assets — lower is better). GENN's score of 25/100 is low — reported earnings may not be fully supported by cash flows.

Valuation

Key valuation multiples comparing the stock's market price to its earnings, revenue, book value, and cash flows. Lower multiples may indicate relative undervaluation versus peers.

P/E
-0.00x
PEG
0.00x
P/S
0.00x
P/B
-0.00x
P/FCF
-0.42x
P/OCF
—
EV/EBITDA
6.03x
EV/Revenue
0.77x
EV/EBIT
10.88x
EV/FCF
-31.66x
Earnings Yield
256.43%
FCF Yield
-240.94%
Shareholder Yield
0.00%
Graham Number
—
Equity-based multiples (P/E, P/B, P/FCF) compare the stock price to per-share fundamentals and are affected by capital structure. Enterprise value multiples (EV/EBITDA, EV/Revenue, EV/FCF) strip out debt and cash, making them more useful for cross-company comparisons regardless of how companies are financed. The Graham Number — √(22.5 × EPS × Book Value) — is Benjamin Graham's formula for the maximum price a defensive investor should pay. GENN currently has negative earnings — the P/E ratio is not meaningful. An earnings yield of 256.4% exceeds typical risk-free rates, suggesting equities are being compensated for risk.

DuPont Decomposition (5-Factor)

The 5-factor DuPont framework breaks Return on Equity into its component drivers — tax efficiency, interest burden, operating profitability, asset utilization, and financial leverage — to reveal what truly drives shareholder returns.

Tax Burden
0.779
NI / EBT
×
Interest Burden
0.469
EBT / EBIT
×
EBIT Margin
0.071
EBIT / Rev
×
Asset Turnover
0.941
Rev / Assets
×
Equity Multiplier
-4.590
Assets / Equity
=
ROE
-11.2%
The 5-factor DuPont identity decomposes ROE as: Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Equity Multiplier = ROE. This reveals whether returns are driven by operating performance, financial leverage, or tax efficiency — three very different sources of profitability. GENN's ROE of -11.2% is driven by Asset Turnover (0.941), indicating efficient use of assets to generate revenue.

Graham-Dodd Adjusted Valuation

Our adaptation of Graham's growth formula (Fair P/E = 8.5 + 2g) from The Intelligent Investor. The classic version relies on analyst growth projections, which can be unreliable. This adjusted model substitutes the company's realized 3-year EPS CAGR — a backward-looking, verifiable measure of actual earnings power — grounding the valuation in demonstrated performance rather than forecasts.

Two adjustments we make, and why. Growth is capped at 15%. Graham defined g as expected growth over the next seven to ten years, not last year's rate. Across US companies since 1994 the median realized 7-year EPS growth is 5–8% regardless of how fast a company grew beforehand, and of 4,457 company-quarters that grew faster than 200%, none sustained it. Uncapped, the formula assigned fair multiples in the hundreds to companies that had never held that rate — and scored worse than simply reading the P/E. Capped, it carries real information. The verdict has three states, not two. Tested over 377,249 stock-months, this ratio only separates outcomes at its extremes: below 0.25 beat the universe by 1.3 points a year, above 3.0 lagged by 2.7, and everything in between sat inside a one-point band. Rather than call two-thirds of the market "undervalued" on a threshold of 1.0, we say Neutral where the model cannot tell — which is most of the time.

Adj. Growth Rate
0.00%
Fair P/E
8.50x
Intrinsic Value
$4.38
Price/Value
0.05x
Margin of Safety
95.41%
Premium
-95.41%
Assessment
Undervalued
Graham's classic formula uses analyst-projected growth to estimate a fair P/E (8.5 + 2g). Our adjusted version replaces that projection with GENN's realized 0.0% 3-year EPS CAGR, capped at 15% — demonstrated performance rather than forecasts, held to a rate companies have historically sustained. At an intrinsic value of $4.38, GENN appears undervalued with a 95% margin of safety. The adjusted fair P/E of 8.5x compares to the current market P/E of -0.0x.

Profitability Trends

Historical profitability ratios tracking how efficiently the company converts revenue into returns for shareholders over time.

Leverage & Solvency Trends

Debt and liquidity metrics showing the company's financial leverage and ability to meet short-term and long-term obligations.

Efficiency & Working Capital Trends

Operating efficiency metrics measuring how quickly the company converts inventory to sales, collects receivables, and manages its cash conversion cycle.

Growth Trends (YoY %)

Year-over-year growth rates for key financial metrics, showing the trajectory of revenue, earnings, and cash flow generation.

Earnings Stability

R-squared of linear regression measuring how predictably revenue, earnings, and margins follow a trend over the trailing 5 years. 1.0 = perfectly predictable; lower values indicate erratic or cyclical behavior.

Monte Carlo Price Simulation

Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 1800 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.

Current Price
$0.00
Median 1Y
$0.00
5th Pctile
$0.00
95th Pctile
$0.00
Ann. Volatility
636.9%
25th–75th percentile 5th–95th percentile Median path Historical
All Ratios & Metrics

Complete fundamental data with up to 20 periods of history, sparkline trends, and current values across 13 categories and 130+ financial metrics.

Profitability
Metric Trend Q4'16 Q1'17 Q2'17 Q3'17 Q4'17 Q1'18 Q2'18 Q3'18 Q4'18 Q1'19 Q2'19 Q3'19 Q4'19 Q1'20 Q2'20 Q3'20 Q4'20 Q1'21 Q2'21 Q3'21 Current
ROE 13.8% 14.0% 20.4% 62.1% 73.5% 69.9% 62.3% 22.6% 19.4% 18.7% 14.6% 4.2% -1.4% -8.4% -6.0% 8.0% 7.5% 15.6% 4.0% -11.2% -11.24%
ROA -1.1% -1.2% -2.0% -8.6% -11.0% -11.4% -11.4% -5.5% -5.2% -3.8% -3.2% -0.9% 0.3% 1.4% 1.0% -1.4% -1.4% -3.0% -0.8% 2.4% 2.45%
ROIC 4.5% 4.3% 4.1% 3.9% 3.7% 3.9% 3.9% 1.2% 1.6% 2.6% 3.6% 13.2% 12.7% 22.6% 28.8% 21.6% 21.1% 9.8% 5.3% -7.9% -7.94%
ROCE 8.0% 7.6% 6.1% 44.1% -12.1% -12.9% -13.0% 1.1% 2.7% 2.9% 2.7% 4.7% 5.3% 6.8% 5.9% 1.2% 13.1% -43.2% 32.8% 85.3% 85.28%
Gross Margin 40.5% 40.6% 44.9% 43.8% 44.8% 43.4% 44.5% 44.1% 43.9% 44.7% 45.3% 44.8% 47.5% 46.8% 35.5% 43.0% 43.0% -3.4% 6.8% 2.8% 2.77%
Operating Margin 3.2% 3.8% 4.9% 2.8% 2.0% 4.4% 4.8% -7.5% 4.0% 8.9% 9.3% 31.2% 1.9% 33.0% 19.9% 27.6% -7.4% -8.4% 1.6% -1.8% -1.82%
Net Margin 1.6% -3.7% -4.9% -28.4% -6.7% -5.3% -3.1% -4.8% -5.8% -1.3% -0.4% 4.1% -1.0% 3.1% -2.3% -6.7% -0.8% -3.6% 8.8% 7.4% 7.40%
EBITDA Margin 16.7% 7.7% 6.1% -32.7% 2.0% 4.5% 9.3% 6.2% 4.9% 8.1% 8.9% 11.6% 4.0% 12.1% 0.5% -4.0% 4.1% 5.7% 24.3% 19.5% 19.51%
FCF Margin -0.4% 0.0% 0.6% 0.5% 1.0% 0.2% 0.1% 0.2% -0.7% -0.4% -0.4% -0.8% -1.5% -1.4% 5.6% 4.9% 6.7% 5.5% -2.6% -2.4% -2.45%
OCF Margin 1.2% 1.6% 2.1% 1.8% 2.2% 1.3% 1.2% 1.3% 0.4% 0.8% 0.9% 0.4% -0.2% -0.1% 6.9% 6.3% 8.1% 6.8% -1.4% -1.2% -1.23%
ROA 3Y Avg snapshot only 0.18%
ROIC 3Y Avg snapshot only -3.67%
ROIC Economic snapshot only -7.44%
Cash ROA snapshot only -1.39%
Cash ROIC snapshot only -2.27%
CROIC snapshot only -4.52%
NOPAT Margin snapshot only -4.29%
Pretax Margin snapshot only 3.34%
R&D / Revenue snapshot only 0.00%
SGA / Revenue snapshot only 7.60%
SBC / Revenue snapshot only 0.03%
Valuation
Metric Trend Q4'16 Q1'17 Q2'17 Q3'17 Q4'17 Q1'18 Q2'18 Q3'18 Q4'18 Q1'19 Q2'19 Q3'19 Q4'19 Q1'20 Q2'20 Q3'20 Q4'20 Q1'21 Q2'21 Q3'21 Current
P/E Ratio -6.13 -3.38 -1.42 -0.24 -0.13 -0.25 -0.40 -0.54 -0.51 -0.82 -0.90 -2.79 12.27 2.23 1.66 -0.98 -0.93 -0.26 -1.73 0.39 -0.000
P/S Ratio 0.07 0.04 0.03 0.02 0.01 0.03 0.04 0.03 0.02 0.03 0.03 0.03 0.04 0.03 0.02 0.01 0.01 0.01 0.02 0.01 0.000
P/B Ratio -0.80 -0.44 -0.26 -0.11 -0.07 -0.13 -0.19 -0.11 -0.09 -0.19 -0.17 -0.16 -0.24 -0.19 -0.10 -0.08 -0.07 -0.04 -0.07 -0.05 -0.000
P/FCF -15.85 100.03 4.65 3.72 1.31 17.63 42.81 13.56 -3.72 -6.98 -7.63 -3.28 -2.57 -2.19 0.32 0.31 0.21 0.16 -0.57 -0.42 -0.415
P/OCF 5.74 2.74 1.42 1.10 0.61 2.13 3.67 2.06 6.52 4.06 3.07 5.92 — — 0.26 0.24 0.17 0.13 — — —
EV/EBITDA 8.31 8.34 9.56 -842.96 -23.58 -19.48 -22.37 17.98 16.17 13.35 13.85 11.70 12.48 11.08 12.80 27.10 26.80 59.99 11.21 6.03 6.025
EV/Revenue 0.94 0.92 0.93 0.94 0.94 0.97 0.97 0.98 1.01 0.95 0.97 0.98 1.02 1.01 0.93 0.95 0.94 0.91 0.78 0.77 0.774
EV/EBIT 13.69 14.16 17.81 -20.13 -10.75 -10.13 -10.73 130.78 56.37 42.49 46.54 26.32 24.50 19.14 20.42 102.05 128.35 -54.51 39.44 10.88 10.877
EV/FCF -217.33 2150.82 147.39 172.38 89.72 608.69 944.12 490.25 -153.85 -215.75 -263.56 -123.09 -66.46 -70.36 16.71 19.50 14.04 16.51 -29.55 -31.66 -31.664
Earnings Yield -16.3% -29.6% -70.2% -4.2% -7.8% -4.0% -2.5% -1.8% -1.9% -1.2% -1.1% -35.8% 8.1% 44.9% 60.2% -1.0% -1.1% -3.9% -57.7% 2.6% 2.56%
FCF Yield -6.3% 1.0% 21.5% 26.9% 76.4% 5.7% 2.3% 7.4% -26.9% -14.3% -13.1% -30.5% -39.0% -45.8% 3.1% 3.3% 4.7% 6.3% -1.7% -2.4% -2.41%
PEG Ratio snapshot only 0.000
EV/Gross Profit snapshot only 5.967
Shareholder Yield snapshot only 0.00%
Leverage & Solvency
Metric Trend Q4'16 Q1'17 Q2'17 Q3'17 Q4'17 Q1'18 Q2'18 Q3'18 Q4'18 Q1'19 Q2'19 Q3'19 Q4'19 Q1'20 Q2'20 Q3'20 Q4'20 Q1'21 Q2'21 Q3'21 Current
Current Ratio 1.23 1.25 1.26 0.18 1.05 1.11 1.03 0.97 0.96 0.83 0.77 0.76 0.77 0.79 0.90 0.94 0.23 0.22 0.25 0.26 0.257
Quick Ratio 1.23 1.25 1.26 0.18 1.05 1.11 1.03 0.97 0.96 0.83 0.77 0.76 0.77 0.79 0.90 0.94 0.23 0.22 0.25 0.26 0.257
Debt/Equity -10.28 -9.16 -8.19 -5.10 -4.65 -4.34 -4.05 -3.84 -3.67 -5.71 -5.59 -5.90 -5.88 -6.08 -5.52 -4.96 -4.65 -4.06 -3.64 -3.68 -3.676
Net Debt/Equity — — — — — — — — — — — — — — — — — — — — —
Debt/Assets 0.87 0.88 0.92 1.02 1.05 1.05 1.08 1.11 1.15 0.94 0.96 0.95 0.96 0.99 0.95 0.96 0.94 0.95 0.94 0.93 0.926
Debt/EBITDA 7.78 8.04 9.38 -833.13 -23.49 -19.13 -21.70 17.57 15.85 12.96 13.49 11.48 12.03 10.80 13.36 28.07 27.95 63.42 11.91 6.38 6.379
Net Debt/EBITDA 7.70 7.95 9.26 -824.78 -23.23 -18.91 -21.35 17.49 15.78 12.92 13.45 11.39 11.99 10.74 12.55 26.67 26.39 59.42 10.99 5.95 5.946
Interest Coverage 0.74 0.71 0.57 -0.51 -0.94 -1.03 -0.98 0.08 0.19 0.27 0.29 0.67 1.05 1.44 1.36 0.27 0.21 -0.47 0.53 1.88 1.885
Equity Multiplier -11.79 -10.37 -8.95 -4.98 -4.42 -4.12 -3.74 -3.45 -3.18 -6.09 -5.83 -6.24 -6.13 -6.17 -5.78 -5.16 -4.95 -4.27 -3.87 -3.97 -3.972
Cash Ratio snapshot only 0.069
Debt Service Coverage snapshot only 3.402
Cash to Debt snapshot only 0.068
FCF to Debt snapshot only -0.030
Defensive Interval snapshot only 355.6 days
Efficiency & Turnover
Metric Trend Q4'16 Q1'17 Q2'17 Q3'17 Q4'17 Q1'18 Q2'18 Q3'18 Q4'18 Q1'19 Q2'19 Q3'19 Q4'19 Q1'20 Q2'20 Q3'20 Q4'20 Q1'21 Q2'21 Q3'21 Current
Asset Turnover 0.97 0.97 0.97 1.01 1.02 1.01 1.04 1.10 1.10 1.01 1.03 1.02 1.02 0.97 0.96 0.93 0.90 0.90 0.95 0.94 0.941
Inventory Turnover — — — — — — — — — — — — — — — — — — — — —
Receivables Turnover 7.07 6.93 7.05 6.81 6.91 6.89 7.23 7.22 7.39 7.29 7.55 7.77 7.67 7.78 8.46 8.23 7.86 7.72 8.65 8.13 8.126
Payables Turnover 13.69 13.87 14.56 13.49 11.16 11.47 12.03 11.88 10.71 10.77 10.84 10.34 10.50 11.10 10.94 10.47 10.03 13.86 13.67 16.30 16.296
DSO 52 53 52 54 53 53 50 51 49 50 48 47 48 47 43 44 46 47 42 45 44.9 days
DIO 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.0 days
DPO 27 26 25 27 33 32 30 31 34 34 34 35 35 33 33 35 36 26 27 22 22.4 days
Cash Conversion Cycle 25 26 27 27 20 21 20 20 15 16 15 12 13 14 10 9 10 21 15 23 22.5 days
Fixed Asset Turnover snapshot only 1.801
Cash Velocity snapshot only 17.959
Capital Intensity snapshot only 0.886
Growth (YoY)
Metric Trend Q4'16 Q1'17 Q2'17 Q3'17 Q4'17 Q1'18 Q2'18 Q3'18 Q4'18 Q1'19 Q2'19 Q3'19 Q4'19 Q1'20 Q2'20 Q3'20 Q4'20 Q1'21 Q2'21 Q3'21 Current
Revenue 2.0% -1.7% -3.7% -5.6% -6.3% -6.4% -6.0% -6.1% -7.4% -8.5% -9.7% -9.8% -8.3% -7.0% -8.5% -10.7% -14.4% -17.4% -17.2% -17.5% -17.54%
Net Income 85.0% 79.9% 68.4% -32.8% -8.0% -7.3% -4.0% 45.3% 59.4% 69.5% 74.2% 83.2% 1.1% 1.3% 1.3% -46.0% -5.0% -3.0% -1.7% 2.4% 2.41%
EPS 85.5% 80.5% 69.7% -26.2% -7.6% -6.8% -3.6% 49.3% 61.7% 71.1% 75.7% 84.1% 1.1% 1.2% 1.3% -39.5% -4.9% -3.9% -1.4% 1.9% 1.93%
FCF 67.9% 1.0% 1.6% 1.7% 3.3% 2.5% -84.6% -65.6% -1.6% -3.5% -4.2% -4.6% -1.1% -2.0% 14.8% 6.5% 4.7% 4.2% -1.4% -1.4% -1.41%
EBITDA 65.0% 34.7% 9.7% -1.0% -1.3% -1.4% -1.4% 46.9% 2.4% 2.3% 2.5% 38.4% 20.2% 18.5% -5.5% -62.5% -63.4% -86.3% -20.1% 2.0% 2.03%
Op. Income -16.5% -19.4% -18.7% -24.8% -28.2% -21.9% -20.5% -73.4% -59.9% -35.4% -8.7% 10.4% 6.9% 6.0% 4.6% 36.5% 27.2% -63.6% -86.0% -1.2% -1.17%
OCF Growth snapshot only -1.16%
Asset Growth snapshot only -28.55%
Debt Growth snapshot only -31.18%
Shares Change snapshot only 51.72%
Growth (CAGR)
Metric Trend Q4'16 Q1'17 Q2'17 Q3'17 Q4'17 Q1'18 Q2'18 Q3'18 Q4'18 Q1'19 Q2'19 Q3'19 Q4'19 Q1'20 Q2'20 Q3'20 Q4'20 Q1'21 Q2'21 Q3'21 Current
Revenue 3Y 90.6% 90.3% 89.5% 88.4% 86.6% 39.1% 18.0% 5.3% -4.0% -5.6% -6.5% -7.2% -7.3% -7.3% -8.1% -8.9% -10.1% -11.1% -11.9% -12.8% -12.75%
Revenue 5Y 45.8% 45.5% 44.9% 44.4% 43.8% 43.5% 43.4% 43.1% 43.1% 42.6% 42.0% 41.5% 40.7% 18.0% 6.3% -1.2% -7.0% -8.4% -9.2% -10.0% -10.04%
EPS 3Y — — — — — — — — — — — — — — — — — — — — —
EPS 5Y — — — — — — — — — — — — — — — — — — — — —
Net Income 3Y — — — — — — — — — — — — — — — — — — — — —
Net Income 5Y — — — — — — — — — — — — — — — — — — — — —
EBITDA 3Y 1.3% 1.3% 1.4% — — — — -5.1% -7.6% -9.3% -12.4% -7.9% -16.8% -13.1% -16.6% — — — — 16.3% 16.25%
EBITDA 5Y — — — — — — — 36.9% 43.5% 47.7% 51.5% 45.9% 47.1% 34.1% 6.6% -15.0% -19.1% -34.4% -12.7% -2.3% -2.35%
Gross Profit 3Y 2.0% 2.0% 2.0% 2.0% 1.9% 55.3% 24.3% 8.8% -2.0% -3.4% -4.3% -4.8% -4.1% -3.7% -6.5% -8.1% -11.0% -22.0% -29.0% -42.0% -42.02%
Gross Profit 5Y 72.8% 74.7% 76.4% 78.7% 80.2% 82.5% 85.2% 87.1% 89.8% 90.2% 89.3% 87.4% 86.3% 27.2% 9.6% 0.4% -6.7% -14.2% -19.2% -28.7% -28.68%
Op. Income 3Y 1.2% 1.1% 1.4% 80.1% 84.1% 24.0% -0.5% -40.7% -37.8% -25.9% -16.1% 31.8% 31.8% 52.1% 59.2% 60.7% 59.5% 18.0% -10.8% — —
Op. Income 5Y 20.0% 20.9% 21.4% 21.0% 19.8% 23.1% 25.8% 11.2% 23.5% 37.7% 58.1% 77.8% 81.9% 53.7% 38.0% 26.6% 19.5% 0.7% -14.4% — —
FCF 3Y — -58.8% -5.7% -0.2% 61.7% — — — — — — — — — 89.9% 89.2% 66.5% 1.9% — — —
FCF 5Y — -48.9% -7.5% -8.7% 19.5% -22.3% -25.8% -20.2% — — — — — — — — — — — — —
OCF 3Y 12.6% 21.7% 27.2% 33.1% 66.0% 56.8% — — 29.2% 1.2% 2.7% -25.4% — — 37.7% 37.0% 37.9% 53.4% — — —
OCF 5Y -7.1% 0.6% 10.8% 9.4% 23.1% 7.7% 8.2% 6.7% -17.3% -5.6% -4.8% -13.8% — — — — 1.1% 47.9% — — —
Assets 3Y 1.1% 1.1% 1.0% 96.4% 94.5% -7.5% -9.4% -10.5% -11.1% -7.3% -7.9% -7.4% -6.9% -7.6% -7.5% -5.1% -5.3% -7.7% -11.5% -11.8% -11.82%
Assets 5Y 52.7% 52.2% 51.6% 48.4% 47.6% 47.5% 46.0% 46.0% 46.0% 49.3% 48.4% 48.4% 48.3% -5.7% -6.5% -7.2% -7.7% -9.0% -11.9% -12.5% -12.55%
Equity 3Y — — — — — — — — — — — — — — — — — — — — —
Book Value 3Y — — — — — — — — — — — — — — — — — — — — —
Dividend 3Y — — — — — — — — — — — — — — — — — — — — —
Growth Quality
Metric Trend Q4'16 Q1'17 Q2'17 Q3'17 Q4'17 Q1'18 Q2'18 Q3'18 Q4'18 Q1'19 Q2'19 Q3'19 Q4'19 Q1'20 Q2'20 Q3'20 Q4'20 Q1'21 Q2'21 Q3'21 Current
Revenue Stability 0.65 0.75 0.81 0.79 0.70 0.77 0.80 0.72 0.54 0.50 0.47 0.45 0.44 0.36 0.16 0.06 0.90 0.94 0.96 0.97 0.973
Earnings Stability 0.04 0.04 0.08 0.89 0.55 0.61 0.67 0.66 0.31 0.24 0.20 0.03 0.00 0.04 0.07 0.27 0.30 0.20 0.35 0.85 0.846
Margin Stability 0.36 0.50 0.49 0.47 0.47 0.63 0.63 0.62 0.61 0.60 0.60 0.61 0.61 0.86 0.93 0.96 0.96 0.84 0.77 0.63 0.634
Rev. Growth Consistency 1.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.000
Earn. Growth Consistency 0.50 0.50 0.50 0.00 0.00 0.00 0.00 0.50 0.50 0.50 0.50 1.00 1.00 1.00 1.00 0.00 0.00 0.00 0.00 0.50 0.500
FCF Positive Streak 0 0 0 0 0 1 1 1 0 0 0 0 0 0 0 0 0 0 0 0 0
Earnings Persistence 0.50 0.50 0.50 0.87 0.50 0.50 0.50 0.82 0.50 0.50 0.50 0.50 0.20 0.20 0.20 0.82 0.20 0.20 0.20 0.20 0.200
Earnings Smoothness — — — — — — — — — — — — — — — — — — — — —
ROE Trend — — — — — — — — — — — — — — — — — — — — —
Gross Margin Trend 0.15 0.05 0.02 0.02 0.02 0.03 0.03 0.02 0.02 0.02 0.02 0.01 0.02 0.02 -0.00 -0.01 -0.03 -0.15 -0.21 -0.31 -0.311
FCF Margin Trend -0.01 0.01 0.02 0.02 0.02 0.01 0.00 0.00 -0.01 -0.01 -0.01 -0.01 -0.02 -0.01 0.06 0.05 0.08 0.06 -0.05 -0.04 -0.045
Sustainable Growth Rate — — — — — — — — — — — — — — — — — — — — —
Internal Growth Rate — — — — — — — — — — — — 0.3% 1.4% 1.0% — — — — 2.5% 2.51%
Cash Flow Quality
Metric Trend Q4'16 Q1'17 Q2'17 Q3'17 Q4'17 Q1'18 Q2'18 Q3'18 Q4'18 Q1'19 Q2'19 Q3'19 Q4'19 Q1'20 Q2'20 Q3'20 Q4'20 Q1'21 Q2'21 Q3'21 Current
OCF/Net Income -1.07 -1.23 -1.00 -0.21 -0.21 -0.12 -0.11 -0.26 -0.08 -0.20 -0.29 -0.47 -0.49 -0.06 6.44 -4.12 -5.35 -2.01 1.63 -0.47 -0.472
FCF/OCF -0.36 0.03 0.31 0.30 0.47 0.12 0.09 0.15 -1.75 -0.58 -0.40 -1.81 9.75 15.89 0.80 0.78 0.82 0.81 1.85 1.99 1.991
FCF/Net Income snapshot only -0.940
OCF/EBITDA snapshot only -0.096
CapEx/Revenue 1.6% 1.5% 1.4% 1.3% 1.2% 1.2% 1.1% 1.1% 1.0% 1.2% 1.3% 1.2% 1.4% 1.3% 1.4% 1.4% 1.4% 1.3% 1.2% 1.2% 1.22%
CapEx/Depreciation snapshot only 0.212
Accruals Ratio -0.02 -0.03 -0.04 -0.10 -0.13 -0.13 -0.13 -0.07 -0.06 -0.05 -0.04 -0.01 0.00 0.01 -0.06 -0.07 -0.09 -0.09 0.01 0.04 0.036
Sloan Accruals snapshot only -0.600
Cash Flow Adequacy snapshot only -1.009
Earnings Quality Score snapshot only 0.250
Dividends & Buybacks
Metric Trend Q4'16 Q1'17 Q2'17 Q3'17 Q4'17 Q1'18 Q2'18 Q3'18 Q4'18 Q1'19 Q2'19 Q3'19 Q4'19 Q1'20 Q2'20 Q3'20 Q4'20 Q1'21 Q2'21 Q3'21 Current
Dividend Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Dividend/Share $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Payout Ratio — — — — — — — — — — — — 0.0% 0.0% 0.0% — — — — 0.0% 0.00%
FCF Payout Ratio — 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% — — — — — — 0.0% 0.0% 0.0% 0.0% — — —
Total Payout Ratio — — — — — — — — — — — — 0.0% 0.0% 0.0% — — — — 0.0% 0.00%
Div. Increase Streak — — — — — — — — — — — — — — — — — — — — —
Chowder Number — — — — — — — — — — — — — — — — — — — — —
Buyback Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Net Buyback Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Total Shareholder Return 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
DuPont Factors
Metric Trend Q4'16 Q1'17 Q2'17 Q3'17 Q4'17 Q1'18 Q2'18 Q3'18 Q4'18 Q1'19 Q2'19 Q3'19 Q4'19 Q1'20 Q2'20 Q3'20 Q4'20 Q1'21 Q2'21 Q3'21 Current
Tax Burden (NI/EBT) 0.47 0.48 0.52 0.62 0.60 0.60 0.60 0.59 0.63 0.62 0.62 0.50 1.58 0.88 0.90 0.61 0.55 0.64 0.50 0.78 0.779
Interest Burden (EBT/EBIT) -0.34 -0.41 -0.76 2.98 2.06 1.97 2.02 -11.41 -4.22 -2.68 -2.41 -0.50 0.05 0.30 0.26 -2.68 -3.76 3.14 -0.88 0.47 0.469
EBIT Margin 0.07 0.07 0.05 -0.05 -0.09 -0.10 -0.09 0.01 0.02 0.02 0.02 0.04 0.04 0.05 0.05 0.01 0.01 -0.02 0.02 0.07 0.071
Asset Turnover 0.97 0.97 0.97 1.01 1.02 1.01 1.04 1.10 1.10 1.01 1.03 1.02 1.02 0.97 0.96 0.93 0.90 0.90 0.95 0.94 0.941
Equity Multiplier -12.78 -11.40 -10.27 -7.19 -6.71 -6.12 -5.49 -4.12 -3.73 -4.91 -4.56 -4.48 -4.25 -6.13 -5.81 -5.68 -5.52 -5.13 -4.79 -4.59 -4.590
Per Share
Metric Trend Q4'16 Q1'17 Q2'17 Q3'17 Q4'17 Q1'18 Q2'18 Q3'18 Q4'18 Q1'19 Q2'19 Q3'19 Q4'19 Q1'20 Q2'20 Q3'20 Q4'20 Q1'21 Q2'21 Q3'21 Current
EPS (Diluted TTM) $-0.69 $-0.78 $-1.22 $-4.92 $-5.99 $-6.07 $-5.68 $-2.49 $-2.29 $-1.75 $-1.38 $-0.40 $0.13 $0.38 $0.42 $-0.55 $-0.52 $-1.10 $-0.18 $0.52 $0.52
Book Value/Share $-5.31 $-5.97 $-6.61 $-10.42 $-11.21 $-11.80 $-12.09 $-12.42 $-13.05 $-7.57 $-7.45 $-6.93 $-6.96 $-4.35 $-6.79 $-7.21 $-7.24 $-7.70 $-4.80 $-4.42 $-10.39
Tangible Book/Share $-11.98 $-12.60 $-13.06 $-12.87 $-13.57 $-14.08 $-14.25 $-14.48 $-15.05 $-9.32 $-9.12 $-8.55 $-8.54 $-5.37 $-8.32 $-8.71 $-8.72 $-9.91 $-6.28 $-5.87 $-5.87
Revenue/Share $62.08 $61.49 $59.53 $57.39 $55.56 $53.80 $51.86 $49.94 $48.49 $46.64 $44.08 $42.70 $41.74 $26.86 $38.73 $36.44 $34.48 $32.57 $21.03 $19.80 $34.92
FCF/Share $-0.27 $0.03 $0.37 $0.31 $0.58 $0.09 $0.05 $0.10 $-0.32 $-0.21 $-0.16 $-0.34 $-0.64 $-0.39 $2.15 $1.77 $2.30 $1.79 $-0.56 $-0.48 $2.33
OCF/Share $0.74 $0.96 $1.22 $1.06 $1.25 $0.71 $0.62 $0.66 $0.18 $0.35 $0.40 $0.19 $-0.07 $-0.02 $2.67 $2.28 $2.79 $2.21 $-0.30 $-0.24 $2.82
Cash/Share $0.56 $0.56 $0.69 $0.53 $0.56 $0.59 $0.78 $0.23 $0.20 $0.14 $0.11 $0.32 $0.11 $0.14 $2.26 $1.78 $1.87 $1.98 $1.36 $1.10 $1.90
EBITDA/Share $7.01 $6.81 $5.77 $-0.06 $-2.22 $-2.68 $-2.26 $2.71 $3.02 $3.33 $3.09 $3.56 $3.40 $2.45 $2.81 $1.28 $1.20 $0.49 $1.47 $2.55 $2.55
Debt/Share $54.58 $54.69 $54.12 $53.16 $52.08 $51.22 $49.00 $47.67 $47.85 $43.22 $41.68 $40.89 $40.94 $26.42 $37.48 $35.79 $33.63 $31.28 $17.50 $16.24 $16.24
Net Debt/Share $54.02 $54.13 $53.43 $52.63 $51.51 $50.63 $48.21 $47.45 $47.65 $43.08 $41.57 $40.56 $40.83 $26.28 $35.22 $34.02 $31.76 $29.31 $16.15 $15.13 $15.13
Academic Models
Metric Trend Q4'16 Q1'17 Q2'17 Q3'17 Q4'17 Q1'18 Q2'18 Q3'18 Q4'18 Q1'19 Q2'19 Q3'19 Q4'19 Q1'20 Q2'20 Q3'20 Q4'20 Q1'21 Q2'21 Q3'21 Current
Altman Z-Score — — — — — — — — — — — — — — — — — — — — 0.140
Altman Z-Prime snapshot only -4.917
Piotroski F-Score 5 4 4 4 4 4 3 5 3 5 5 5 4 3 6 3 3 4 1 3 3
Beneish M-Score -2.53 -2.61 -2.81 -3.34 -3.58 -3.42 -3.33 -2.84 -2.79 -3.09 -3.10 -2.97 -2.83 -2.57 -2.86 -3.00 -3.09 -10.86 -0.29 5.37 5.371
Ohlson O-Score snapshot only -3.140
Net-Net WC snapshot only $-19.47
EVA snapshot only $-329939410.15
Credit
Metric Trend Q4'16 Q1'17 Q2'17 Q3'17 Q4'17 Q1'18 Q2'18 Q3'18 Q4'18 Q1'19 Q2'19 Q3'19 Q4'19 Q1'20 Q2'20 Q3'20 Q4'20 Q1'21 Q2'21 Q3'21 Current
Credit Rating snapshot only CCC
Credit Score 20.00 20.00 20.00 14.94 20.00 20.00 20.00 16.24 15.80 16.27 12.68 13.09 15.39 15.81 20.00 17.38 9.79 8.14 8.16 17.35 17.345
Credit Grade snapshot only 17
Credit Trend snapshot only -0.034
Implied Spread (bps) snapshot only 1200.000
Industry Credit Rank snapshot only 7
Sector Credit Rank snapshot only 6

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms